Childhood immunization begins recovery after COVID-19 backslide
The health sector has faced considerable disruption due to the COVID-19 pandemic, but a new report from the World Health Organization (WHO) and UNICEF brings a ray of hope. The…
Indian Immunologicals administers 1 Lac FREE dosages of Anti-rabies vaccine on World Zoonosis Day 2023
Indian Immunologicals Limited (IIL), one of India’s leading biotechnology companies dedicated to manufacturing and supplying life-saving vaccines, commemorated World Zoonoses Day on July 6th, 2023. This significant occasion highlights the…
Rising from the Shadows of COVID-19: The Fight Against Avascular Necrosis at Wockhardt Hospitals
The post-COVID era has ushered in a set of challenges for the healthcare industry, one of which is the increasingly prevalent condition, Avascular Necrosis (AVN), or bone death. Wockhardt Hospitals…
Making Hygiene Matter: Report Highlights the Importance of Hygiene in Pandemic Preparedness
The Global Hygiene Council (GHC) has released a report calling for urgent action to prioritize hygiene in home and community settings in pandemic preparedness plans. Titled “Making Hygiene Matter,” the…
Increase in Osteoporosis cases post-Covid19 due to psychological effects
The past two years of COVID19 pandemic have not just impacted our physical health or mental health but also impacted the way we think. While the pandemic outbreak was ongoing,…
The Gamaleya Center study in animals shows the intranasally delivered Sputnik V vaccine induces robust and durable immune response to coronavirus
The Gamaleya National Research Center of Epidemiology and Microbiology (Gamaleya Center) and the Russian Direct Investment Fund announce a publication in Emerging Microbes & Infections, a peer-reviewed medical journal, sharing…
PFIZER RANKED AS LEADING COMPANY IN ASIA FOR COVID-19 RESPONSE AND PATIENT-CENTRIC APPROACH BY ASIAN PATIENT GROUPS
Pfizer had been ranked first in its Covid-19 response, patient centricity, patient safety and bringing innovative, high-quality products amongst pharma companies in Asia in the ‘Corporate Reputation of Pharma’ survey…
The Gamaleya Center has developed a Delta- and Omicron-adapted Sputnik V vaccine
The Gamaleya National Research Center of Epidemiology and Microbiology (Gamaleya Center) and the Russian Direct Investment Fund announce the development of the Sputnik V vaccine specifically adapted against Delta and…
